Takimoto R - Search Results

1

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T. Kurosawa M, et al. Among authors: takimoto r. Int J Hematol. 2012 Dec;96(6):748-57. doi: 10.1007/s12185-012-1210-y. Epub 2012 Oct 31. Int J Hematol. 2012. PMID: 23111539

2

A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T. Torimoto Y, et al. Among authors: takimoto r. Int J Hematol. 2013 Aug;98(2):171-8. doi: 10.1007/s12185-013-1383-z. Epub 2013 Jun 29. Int J Hematol. 2013. PMID: 23813410 Clinical Trial.

3

Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.

Hirayama Y, Ishitani K, Ota S, Kurosawa M, Kondo T, Takimoto R, Mori A, Sakai H, Torimoto Y, Yamamoto S, Sato K, Iwasaki H, Kohda K, Ishida T, Kakinoki Y, Fukuhara T, Kato J. Hirayama Y, et al. Among authors: takimoto r. Int J Hematol. 2014 Sep;100(3):281-9. doi: 10.1007/s12185-014-1629-4. Epub 2014 Jul 23. Int J Hematol. 2014. PMID: 25052874

4

Recovery of neutrophil count by ganciclovir in patients with chronic idiopathic neutropenia associated with cytomegalovirus infection in bone marrow stromal cells.

Hirayama Y, Sakamaki S, Tsuji Y, Chiba H, Matsunaga T, Takimoto R, Kato J, Niitsu Y. Hirayama Y, et al. Among authors: takimoto r. Int J Hematol. 2004 May;79(4):337-9. doi: 10.1532/ijh97.03155. Int J Hematol. 2004. PMID: 15218961

5

A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer.

Hayashi T, Ishiwatari H, Yoshida M, Sato T, Miyanishi K, Sato Y, Kobune M, Takimoto R, Sonoda T, Kato J. Hayashi T, et al. Among authors: takimoto r. Int J Clin Oncol. 2012 Oct;17(5):491-7. doi: 10.1007/s10147-011-0320-5. Epub 2011 Sep 21. Int J Clin Oncol. 2012. PMID: 21932164 Clinical Trial.

6

[Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib].

Murase K, Matsunaga T, Takeuchi N, Fujimi A, Takimoto R, Terui T, Hirayama Y, Niitsu Y. Murase K, et al. Among authors: takimoto r. Rinsho Ketsueki. 2004 Sep;45(9):1028-32. Rinsho Ketsueki. 2004. PMID: 15510830 Japanese.

7

[Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia].

Hirayama Y, Terui T, Koike K, Neda H, Ishitani K, Kohda K, Kuroda H, Iyama S, Sato T, Kobune M, Takimoto R, Kato J. Hirayama Y, et al. Among authors: takimoto r. Rinsho Ketsueki. 2009 Aug;50(8):663-5. Rinsho Ketsueki. 2009. PMID: 19915382 Japanese.

8

[Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib].

Araki N, Takimoto R, Fujimi A, Murase K, Araki H, Takahira N, Matsunaga T, Terui T, Kogawa K, Hirayama Y, Kato J, Niitsu Y. Araki N, et al. Among authors: takimoto r. Rinsho Ketsueki. 2007 Jun;48(6):518-23. Rinsho Ketsueki. 2007. PMID: 17633103 Japanese.

9

Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.

Ishiwatari H, Hayashi T, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J. Ishiwatari H, et al. Among authors: takimoto r. Cancer Chemother Pharmacol. 2015 Apr;75(4):805-12. doi: 10.1007/s00280-015-2704-0. Epub 2015 Feb 17. Cancer Chemother Pharmacol. 2015. PMID: 25687990 Clinical Trial.

10

Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome.

Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y, Takada K, Ono K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kato J. Kikuchi S, et al. Among authors: takimoto r. Int J Hematol. 2012 May;95(5):527-34. doi: 10.1007/s12185-012-1048-3. Epub 2012 Mar 11. Int J Hematol. 2012. PMID: 22407873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters